(Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -71.38%-4.75M | 53.22%-5.38M | -44.03%-2.9M | 121.73%835K | 81.10%-552K | -1.35%-2.77M | -6.72%-11.51M | 51.21%-2.01M | -610.17%-3.84M | 30.12%-2.92M |
Net income from continuing operations | 23.42%-4.4M | 66.10%-12.52M | 95.56%-1.35M | -537.06%-1.99M | -46.73%-3.44M | -23.74%-5.74M | -90.37%-36.93M | -537.58%-30.4M | 107.11%456K | 47.05%-2.34M |
Operating gains losses | 4,260.00%436K | -98.25%28K | 80.35%-91K | -60.90%610K | -164.73%-501K | 103.75%10K | 555.68%1.6M | -309.73%-463K | 245.13%1.56M | 366.90%774K |
Depreciation and amortization | 4.92%512K | -5.22%2.2M | -21.15%727K | -2.61%486K | -1.97%498K | 24.81%488K | 17.71%2.32M | 100.87%922K | 23.82%499K | 32.29%508K |
Asset impairment expenditure | ---- | --0 | ---- | ---- | ---- | ---- | --34.21M | ---- | ---- | ---- |
Remuneration paid in stock | -115.95%-56K | -93.75%152K | -52.08%207K | -63.80%122K | -178.69%-528K | -64.65%351K | -46.10%2.43M | -59.63%432K | -81.14%337K | -51.24%671K |
Deferred tax | 1,325.00%49K | 92.57%-520K | 91.04%-668K | -67.10%152K | --0 | -136.36%-4K | -476.61%-7M | -1,336.61%-7.46M | 314.88%462K | 92.89%-17K |
Other non cashItems | -8.85%1.11M | 193.46%3.96M | -25.07%284K | 147.77%1.18M | 135.61%1.27M | -14.56%1.22M | -157.21%-4.23M | -72.79%379K | -166.92%-2.47M | -366.99%-3.58M |
Change In working capital | -366.96%-2.41M | 133.70%1.32M | -653.87%-2.01M | 105.97%280K | 102.07%2.14M | 238.13%902K | -6.12%-3.92M | 122.18%362K | -1,895.74%-4.69M | 145.63%1.06M |
-Change in receivables | -145.72%-1.11M | 254.01%2.59M | -252.17%-210K | 157.94%2.1M | -195.15%-1.73M | 27,077.78%2.43M | 42.38%-1.68M | 106.41%138K | -728.31%-3.63M | 215.30%1.82M |
-Change in prepaid assets | -105.18%-1.51M | 115.51%194K | 241.98%876K | -239.33%-124K | 180.37%176K | -45.63%-734K | -402.41%-1.25M | -61,600.00%-617K | -91.40%89K | 44.42%-219K |
-Change in payables and accrued expense | 74.63%-445K | -222.26%-1.36M | -112.72%-131K | -177.29%-262K | 54.22%785K | -129.58%-1.75M | 135.02%1.11M | -28.72%1.03M | 171.82%339K | 202.62%509K |
-Change in other working capital | -32.12%653K | 95.10%-103K | -1,243.92%-2.54M | 3.62%-1.44M | 378.56%2.91M | 54.17%962K | -110.42%-2.1M | 79.52%-189K | -313.89%-1.49M | -846.43%-1.05M |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -71.38%-4.75M | 53.22%-5.38M | -44.03%-2.9M | 121.73%835K | 81.10%-552K | -1.35%-2.77M | -6.82%-11.51M | 51.09%-2.01M | -610.17%-3.84M | 30.12%-2.92M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 15,440.00%1.53M | 506.67%6.89M | 1,893.28%6.94M | 86.78%-23K | 98.33%-18K | 81.13%-10K | -52.61%-1.69M | 58.30%-387K | -127.53%-174K | -204.23%-1.08M |
Capital expenditure reported | ---- | --0 | ---- | ---- | ---- | ---- | -200.00%-505K | ---- | ---- | ---- |
Net PPE purchase and sale | -450.00%-55K | 52.27%-168K | -150.61%-125K | 86.55%-23K | 97.37%-10K | 79.17%-10K | 77.57%-352K | 384.31%247K | 82.46%-171K | -50.79%-380K |
Net intangibles purchas and sale | ---- | 99.04%-8K | --0 | --0 | ---- | ---- | -44.81%-837K | 62.28%-129K | 95.52%-3K | -579.61%-700K |
Net business purchase and sale | --1.59M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net other investing changes | ---- | --7.07M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 15,440.00%1.53M | 506.67%6.89M | 1,893.28%6.94M | 86.78%-23K | 98.33%-18K | 81.13%-10K | -52.61%-1.69M | 58.30%-387K | -127.53%-174K | -204.23%-1.08M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -20.98%-467K | 46.75%-1.66M | 78.58%-474K | -34.45%-402K | -31.67%-395K | -28.67%-386K | -108.72%-3.11M | 1.56%-2.21M | -101.45%-299K | -101.84%-300K |
Net issuance payments of debt | -23.80%-437K | -33.89%-1.54M | -22.93%-445K | -42.26%-377K | -37.64%-362K | -36.82%-353K | 20.55%-1.15M | 52.86%-362K | -5.16%-265K | -13.85%-263K |
Cash dividends paid | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
Interest paid (cash flow from financing activities) | 9.09%-30K | 21.05%-120K | 25.64%-29K | 26.47%-25K | 10.81%-33K | 21.43%-33K | 29.30%-152K | 15.22%-39K | 34.62%-34K | 33.93%-37K |
Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | -26.36%-1.81M | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -20.98%-467K | 46.75%-1.66M | 78.58%-474K | -34.45%-402K | -31.67%-395K | -28.67%-386K | -108.72%-3.11M | 1.56%-2.21M | -101.45%-299K | -101.84%-300K |
Net cash flow | ||||||||||
Beginning cash position | 2.77%13.93M | -54.16%13.56M | -45.18%9.7M | -57.64%9.32M | -60.45%10.42M | -54.16%13.56M | 429.58%29.58M | -51.17%17.69M | 40.43%21.99M | 572.63%26.35M |
Current changes in cash | -16.26%-3.68M | 99.07%-151K | 177.46%3.57M | 109.50%410K | 77.56%-965K | -2.59%-3.17M | -168.52%-16.31M | 36.73%-4.61M | -120.78%-4.32M | -136.50%-4.3M |
Effect of exchange rate changes | -746.67%-194K | 79.86%527K | 38.38%667K | -444.44%-31K | -152.73%-139K | 120.98%30K | 59.24%293K | -25.27%482K | 104.35%9K | -30.95%-55K |
End cash Position | -3.48%10.06M | 2.77%13.93M | 2.77%13.93M | -45.18%9.7M | -57.64%9.32M | -60.45%10.42M | -54.16%13.56M | -54.16%13.56M | -51.17%17.69M | 40.43%21.99M |
Free cash from | -72.74%-4.8M | 59.44%-5.56M | -4.07%-3.02M | 120.22%812K | 85.75%-570K | 0.22%-2.78M | -6.61%-13.71M | 47.04%-2.9M | -810.66%-4.02M | 11.78%-4M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.